Trial Profile
Intravitreal injection of Pegaptanib(Macugen) for chronic central serous chorioretinopathy
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Dec 2014
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Central serous chorioretinopathy
- Focus Therapeutic Use
- 17 Dec 2014 New trial record